文献速递乳房整形与再造

二甲基亚砜挽救乳头乳晕复合体缺血:病例系列

Salvage of Nipple-Areolar Complex Ischemia With Dimethyl Sulfoxide: A Case Series.
PubMed 文献 · Ann Plast Surg · 2023-01-31

这项前瞻性病例系列纳入11例乳房手术后出现乳头乳晕复合体(NAC)缺血的患者,局部外用二甲基亚砜(DMSO)每日4次至临床缺血改变消退;从开始DMSO到临床改善或NAC缺血消退平均7.5±2.5天(范围5-12天),所有患者均显著改善或完全消退,11例NAC均成功挽救。

要点

  • 11例乳房手术后NAC缺血患者局部外用DMSO,所有患者均显著改善或完全消退。
  • 从开始DMSO到临床改善或NAC缺血消退平均7.5±2.5天(范围5-12天)。
  • 作者结论认为DMSO是受威胁NAC的安全治疗,结果为进一步随机对照研究奠定基础。

核心结论

  • 作者结论认为DMSO是受威胁NAC的安全治疗,本系列所有患者外用DMSO后NAC缺血显著改善或消退,11例受威胁NAC均成功挽救,这些结果为进一步随机对照研究确定DMSO疗效奠定基础。

研究设计与样本

  • 前瞻性病例系列,通过前瞻性维护的数据库识别由2名乳腺外科医生和1名单名整形外科医生治疗、接受保留乳头乳房切除术或乳房缩小术并出现NAC缺血的患者。
  • 共识别11例患者,平均年龄47.8±9.5岁(范围35-61岁),平均体重指数26.0±4.4 kg/m2(范围20.7-33.4 kg/m2)。
  • 在手术结束时或多数病例术后第1天开始对受累NAC局部外用DMSO,每日4次,直至缺血改变临床消退;收集的人口学、手术和结局变量采用描述性统计进行分析。

主要发现

  • 手术与NAC缺血临床诊断之间的平均时间为1.3±2.8天(范围0-7天)。
  • 从开始DMSO到NAC缺血临床改善或消退的平均时间为7.5±2.5天(范围5-12天)。
  • 所有患者连续局部外用DMSO后均显示NAC缺血显著改善或完全消退,11例患者的受威胁NAC均成功挽救。

临床怎么用

  • 作者认为DMSO是受威胁NAC的安全治疗,本系列所有患者外用DMSO后NAC缺血显著改善或消退。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nipple-areolar complex (NAC) necrosis is a known risk of breast surgery, particularly mastectomy. Disruption of the underlying blood supply to the NAC can lead to ischemia and subsequent necrosis. Nitroglycerin paste is currently used to combat NAC ischemia but has limited efficacy and an unfavorable side effect profile. Topical dimethyl sulfoxide (DMSO) has been shown to increase tissue perfusion in microsurgery and various skin flaps, but its role in the treatment and prevention of NAC ischemia has not been reported. Through a prospective case series, this study aims to introduce DMSO as a safe treatment for NAC ischemia after breast surgery. METHODS: Patients treated by 2 breast surgeons and a single plastic surgeon who underwent nipple-sparing mastectomy or breast reduction and developed NAC ischemia were identified via a prospectively maintained database. Ischemic changes were diagnosed, and treatment to the affected NAC with DMSO was initiated at the conclusion of the procedure, or postoperative day 1 in most cases, and continued 4 times daily until ischemic changes had resolved clinically. Collected demographic, surgical, and outcome variables were analyzed using descriptive statistics. RESULTS: Eleven patients with a mean age of 47.8 ± 9.5 years (range, 35-61 years) and mean body mass index of 26.0 ± 4.4 kg/m2 (range, 20.7-33.4 kg/m2) were identified. The mean duration of time between surgery and the clinical diagnosis of NAC ischemia was 1.3 ± 2.8 days (range, 0-7 days). The average length of time from DMSO initiation to clinical improvement or resolution of NAC ischemia was 7.5 ± 2.5 days (range, 5-12 days). All patients demonstrated significant improvement or complete resolution of NAC ischemia following serial topical DMSO application. CONCLUSIONS: This study demonstrates DMSO is a safe treatment for threatened NACs. All patients in this series showed either dramatic improvement or resolution of NAC ischemia after DMSO application, and threatened NACs of all 11 patients were successfully salvaged. These promising results set the basis for ongoing randomized controlled studies to determine the efficacy of DMSO treatment for NAC ischemia.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Wiesemann GS, Cox EA, Nichols DS, et al. Salvage of Nipple-Areolar Complex Ischemia With Dimethyl Sulfoxide: A Case Series. Ann Plast Surg. 2023. PMID: 36752563. doi:10.1097/SAP.0000000000003461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。